Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

Phase 2

Completed

Conditions: Bladder Cancer
Melanoma

Interventions: Drug: Nivolumab
Drug: Nivolumab plus Ipilimumab

First Posted Date: 2015-09-17

Last Posted Date: 2025-04-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 81

Registration Number: NCT02553642

Locations: 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States

and more 2 locations

Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

Phase 2

Completed

Conditions: Endometrial Cancer
Recurrent Endometrial Cancer

Interventions: Drug: LY3023414

First Posted Date: 2015-09-15

Last Posted Date: 2023-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT02549989

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 3 locations

Lenalidomide Maintenance in Plasma Cell Myeloma

Phase 2

Active, not recruiting

Conditions: Plasma Cell Myeloma

Interventions: Drug: Lenalidomide

First Posted Date: 2015-09-02

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 108

Registration Number: NCT02538198

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 2 locations

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Conditions: Prostate Cancer
Recurrent Prostate Cancer

First Posted Date: 2015-08-24

Last Posted Date: 2020-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02531672

Locations: 🇺🇸
Memoral Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack, New York, United States

and more 2 locations

Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

Active, not recruiting

Conditions: Non-Metastatic Breast Cancer

Interventions: Other: Clinical Assessments
Behavioral: Questionnaires
Other: Saliva sample

First Posted Date: 2015-08-20

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 546

Registration Number: NCT02530177

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers

Phase 2

Completed

Conditions: Lung Cancer
Untreated Stage IV or Recurrent Squamous Cell Lung Cancers

Interventions: Drug: albumin-bound paclitaxel
Drug: gemcitabine

First Posted Date: 2015-08-17

Last Posted Date: 2021-01-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT02525653

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
🇺🇸
Miami Cancer Institute Baptist Health South Florida, Miami, Florida, United States

and more 3 locations

Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection

Phase 3

Active, not recruiting

Conditions: Liver Cancer
Pain Management

Interventions: Other: PCEA
Other: IV PCA

First Posted Date: 2015-08-14

Last Posted Date: 2023-09-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 231

Registration Number: NCT02523443

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (Consent Only), Basking Ridge, New Jersey, United States

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: KIBUR MICRODEVICE
Drug: anthracycline and taxane based chemotherapy

First Posted Date: 2015-08-13

Last Posted Date: 2024-08-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT02521363

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

and more 3 locations

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

Not Applicable

Terminated

Conditions: Acute Myeloid Leukemia (AML)

Interventions: Drug: Induction Chemotherapy
Procedure: G-PBSC Infusion

First Posted Date: 2015-08-11

Last Posted Date: 2018-04-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT02519712

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Randomized Controlled Trial Examining Health Care Access Interventions for Taxi Drivers

Not Applicable

Active, not recruiting

Conditions: Healthcare Access for Taxi Drivers

Interventions: Behavioral: questionnaires

First Posted Date: 2015-07-24

Last Posted Date: 2024-08-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 756

Registration Number: NCT02508363

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy